BSE has notified trading members that Aptus Pharma Limited (Scrip Code: 544529) has fixed May 12, 2026 as the record date for a bonus issue of equity shares. Shareholders will receive 3 bonus equity shares of Rs. 10/- each for every 2 equity shares of Rs. 10/- each held. Trading in the scrip will be on an ex-bonus basis from May 12, 2026.

Key Points

• Bonus ratio: 3 new equity shares for every 2 existing equity shares held
• Face value of bonus shares: Rs. 10/- each
• Record date: May 12, 2026
• Ex-bonus effective date: May 12, 2026 (Settlement No. DR-628/2026-2027)
• Total bonus shares to be allotted: 10,290,000 equity shares as on May 13, 2026
• Market lot revised from 2000 to 5000 shares, effective May 12, 2026

Regulatory Changes

The market lot for Aptus Pharma Limited (Scrip Code: 544529) is being changed pursuant to the bonus issue:

Compliance Requirements

• Trading members must note the ex-bonus effective date of May 12, 2026 and ensure all transactions from that date reflect the adjusted price.
• Trading members must update order/trade systems to reflect the revised market lot of 5000 shares effective May 12, 2026.
• Members should refer to the attached company undertaking letter dated May 08, 2026 for additional details.

Important Dates

• May 8, 2026: BSE notice issued; company undertaking letter dated
• May 12, 2026: Record date for bonus issue; ex-bonus trading begins; revised market lot takes effect (Settlement No. DR-628/2026-2027)
• May 13, 2026: Allotment date for 10,290,000 bonus equity shares

Impact Assessment

Existing shareholders of Aptus Pharma Limited will see a 150% increase in their share count (3 new shares per 2 held), with a proportional adjustment in share price on the ex-bonus date. The market lot increase from 2000 to 5000 reflects the expanded share base post-bonus. This is a significant corporate action for retail and institutional investors holding the scrip, requiring attention to revised lot sizes for trading purposes.